Press release
Antiepileptic Drugs (AEDs) Market Will Generate Record Revenue by 2029
Antiepileptic drugs market is anticipated to grow at a significant CAGR during the forecast period. Antiepileptic drugs (AEDs) are commonly known as anticonvulsants or antiseizure drugs. These drugs are used in the treatment of epileptic seizures. Epilepsy is a central neurological disorder that causes brain activity to become abnormal and further causes seizures or periods of unusual behaviour, sensations and sometimes loss of awareness. Additionally, these drugs are also used to stabilize the mood along with the treatment of bipolar disorders or neuropathic pain.Some major key players in the market include Abbott Laboratories, GlaxoSmithKline plc, and Pfizer Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in January 2022, Sun Pharmaceutical Industries Ltd. announced the launch of a range of Brivaracetam dosage forms at an affordable price for epilepsy treatment in India. Additionally, in June 2021, Glenmark Pharma announced the launch of the anti-epileptic drug, Rufinamide tablets in the US market. Furthermore, in March 2021, Alkem Laboratories has announced the launch of Brivasure, an affordable anti-epileptic drug for the treatment of epilepsy in India.
To Request a Sample of our Report on Antiepileptic Drugs (AEDs) Market: https://www.omrglobal.com/request-sample/antiepileptic-drugs-aeds-market
Market Coverage
• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
Segment Covered-
· By Drug Type
Regions Covered-
· North America
· Europe
· Asia-Pacific
· Rest of the World
Competitive Landscape- Abbott Laboratories, GlaxoSmithKline plc, and Pfizer Inc., among others.
Antiepileptic Drugs Market Report by Segment
By Drug Type
· First Generation AEDs
· Phenytoin (Dilantin, Phenytek)
· Carbamazepine (Carbatrol)
· Oxycarbazepine (Trileptal)
· Valproate (Depakote)
· Others
Second Generation AEDs
· Lamotrigine (Lamictal)
· Pregabalin (Lyrica)
· Rufinamide (Banzel/Inovelon)
· Levetiracetam (Keppra)
· Others
A full Report Antiepileptic Drugs (AEDs) Market is Available @ https://www.omrglobal.com/industry-reports/antiepileptic-drugs-aeds-market
Antiepileptic Drugs Market Report by Region
North America
· United States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest of Europe
Asia-Pacific
· India
· China
· Japan
· South Korea
· Rest of APAC
Rest of the World
• Latin America
• Middle East & Africa
Reasons to buy from us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/antiepileptic-drugs-aeds-market
https://www.somosxbox.com.mx/noticias-urgente/se-preve-que-el-valor-de-mercado-de-los-sensores-activos-de-ruedas-de-ferrocarril-se-amplie-para-2029/112058/
https://perualdia.net/el-mercado-de-poliamidas-sinteticas-y-de-base-biologica-generara-ingresos-record-para-2029-2/
https://ekz-crosstour.ch/news/der-markt-fuer-spezialenzyme-aus-mikroorganismen-wird-bis-2029-ein-erstaunliches-wachstum-verzeichnen/118113/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antiepileptic Drugs (AEDs) Market Will Generate Record Revenue by 2029 here
News-ID: 3221124 • Views: …
More Releases from Orion Market Research

Digital Innovation in Insurance Market Size Analysis, Competitive Insights, Lead …
The Global Digital Innovation in Insurance Market is projected to reach around USD 250 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 9.5% from 2024 to 2033.
Digital Innovation in Insurance Market Overview
The Digital Innovation in Insurance Market encompasses the integration of advanced technologies such as Artificial Intelligence (AI), Blockchain, the Internet of Things (IoT), and Big Data analytics into the insurance sector. These innovations are…

Cigarette Rolling Paper Market - Industry Trends and Forecast to 2033
The Global Cigarette Rolling Paper Market was valued at approximately USD 2.9 billion in 2024 and is projected to reach around USD 41.8 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 34.5% from 2024 to 2033.
Cigarette Rolling Paper Market Overview
The Global Cigarette Rolling Paper Market has experienced significant growth, driven by increasing consumer preference for hand-rolled cigarettes, particularly among younger and budget-conscious smokers. These papers…

Back Glue Market: Emerging Trends and Growth Forecast to 2033
The Global Back Glue Market is projected to reach around USD 3.0 billion by 2033, growing at a compound annual growth rate (CAGR) of approximately 7.1% from 2024 to 2033.
Back Glue Market Overview
The Global Back Glue Market encompasses adhesives designed for various applications, including bookbinding, phone back panels, and other industrial uses. Advancements in technology have led to the development of high-performance back glue adhesives, which are anticipated to drive…

Autopilot Systems Market Overview: Growth, Share, Value, Size, and Scope
The Global Autopilot Systems Market was valued at approximately USD 5.8 billion in 2023 and is projected to reach around USD 10.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of approximately 6.4% from 2024 to 2033.
Autopilot Systems Market Overview
The Global Autopilot Systems Market encompasses advanced flight control systems designed to automate the navigation and operation of aircraft, reducing the need for manual input by pilots. These…
More Releases for Antiepileptic
Top 10 Antiepileptic Drugs Companies Analysis (2025)
The global market for antiepileptic drugs expands with increasing cases of epilepsy. Effective therapies targeted at different types of epilepsy drive the market size, which shapes the market trends.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00004426/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Antiepileptic Drugs Market are:
• GlaxoSmithKline Plc
• Johnson & Johnson Services, Inc.
• Abbott
• Bausch Health Companies Inc.
• Pfizer, Inc.
• Sunovion Pharmaceuticals Inc.
• Novartis AG
• UCB S. A.
• Eisai Co., Ltd.
Contact Us:
If you have any queries about this report or…
Antiepileptic Drugs Market Set to Expand and Industry Forecast, 2023-2032
The global antiepileptic drugs market, catering to the symptomatic treatment of epileptic seizures and related conditions, is on the brink of significant expansion. This comprehensive market analysis reveals substantial growth opportunities, driven by factors such as new drug approvals. Despite challenges, including recent patent expirations, the market is expected to flourish.
𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞: https://www.alliedmarketresearch.com/antiepileptic-drugs-market
𝐊𝐞𝐲 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
➤ In-depth Market Coverage: Professionals gain a thorough understanding…
Antiepileptic Drugs Market Business Strategies, Share, Growth Insights 2028
Antiepileptic drugs are primary treatment type for patients suffering with epilepsy. These medications help to stop seizures among epileptic patients at a significant rate. Some of the medications are taken as a "course of treatment" to fight against epileptic seizures, however these drugs are only preventive form of medication to avoid seizures.
Request Sample PDF Brochure of Antiepileptic Drugs Market Size - Global Analysis with Strategic Developments at: https://www.theinsightpartners.com/sample/TIPRE00004426/?utm_source=OpenPR&utm_medium=10209
The antiepileptic…
Antiepileptic Drugs Market is thriving worldwide by 2029
The global antiepileptic drugs market is anticipated to grow at a considerable CAGR of 2.6% during the forecast period. The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launch, and product innovation to remain competitive in the marketplace. For instance, Therachon Holding AG, a privately owned clinical-stage biotechnology business, has been acquired by…
Antiepileptic Drugs Market Size, Price, Share | Forecast to 2027
Latest Updated Report 2023, The Global Antiepileptic Drugs Market to Growing A CAGR of % during forecast period of 2023-2027. The Market is segmented by Global Antiepileptic Drugs Market Breakdown by Application (Hospital, Pharmacy) by Type (First Generation Drugs, Second Generation Drugs, Pipeline Drugs) and by Geography (North America, South America, Europe, Asia Pacific, MEA).
The Antiepileptic Drugs Market 2023 Report makes available the current and forthcoming technical and financial details…
Antiepileptic Drugs Market Industry Development Scenario and Forecast
Market Introduction
Antiepileptic drugs refer to the anti-seizure drugs and are developed as a part of the idiopathic and asymptomatic treatment of problems related to epileptic. The problems of epileptic involves the repeating acts that normally happen because of wrong sign that are directed to the brain by the nerve cells. Such drugs are also used in the treatment of pain associated with neuropathic.
Request To Download Sample of This Strategic Report:…